Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

31-Aug-22 - 29-Aug-23
Buy Ratio:40%


# Net Buyers:29
# Net Sellers:43

Previous 52 Weeks

01-Sep-21 - 30-Aug-22
Buy Ratio:30%
# Net Buyers:63
# Net Sellers:147
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals, Inc.($58.24K)$556.96M  
Catalent, Inc.--$417.58M  
Eli Lilly & Co--$335.39M  
Chemocentryx, Inc.--$161.73M  
Dicerna Pharmaceuticals Inc--$132.57M  
New Net Buyers
CompanyNet Buy AmountChange
Abbvie Inc.$886.03K$65.28M  
Immunitybio, Inc.$56.63M$56.65M  
Acadia Pharmaceuticals Inc$5.37M$5.66M  
Neurocrine Biosciences Inc$545.95K$4.76M  
Iveric Bio, Inc.$146.49K$3.61M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Incyte Corp$5.64M($113.11M)  
Armata Pharmaceuticals, Inc.--($49.00M)  
Johnson & Johnson($29.30M)($24.31M)  
MacRogenics Inc--($20.18M)  
Alpine Immune Sciences, Inc.--($19.72M)  
New Net Sellers
CompanyNet Buy AmountChange
Ani Pharmaceuticals Inc($9.21M)($9.32M)  
Galectin Therapeutics Inc($98.54K)($411.18K)